MBOT has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
MBOT has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Treasury stock is the portion of shares that a company keeps in their own treasury. Microbot Medical's treasury stock for the quarter that ended in Jun. 2024 was $0.00 Mil.
Treasury stock may have come from a repurchase or buyback from shareholders; or it may have never been issued to the public in the first place.
The historical data trend for Microbot Medical's Treasury Stock can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Microbot Medical Annual Data | |||||||||||||||||||||
Trend | Dec14 | Dec15 | Dec16 | Dec17 | Dec18 | Dec19 | Dec20 | Dec21 | Dec22 | Dec23 | |||||||||||
Treasury Stock | Get a 7-Day Free Trial | -3.38 | - | - | - | - |
Microbot Medical Quarterly Data | ||||||||||||||||||||
Sep19 | Dec19 | Mar20 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | Mar24 | Jun24 | |
Treasury Stock | Get a 7-Day Free Trial | - | - | - | - | - |
The portion of shares that a company keeps in their own treasury. Treasury stock may have come from a repurchase or buyback from shareholders; or it may have never been issued to the public in the first place. These shares don't pay dividends, have no voting rights, and should not be included in shares outstanding calculations.
Rachel Vaknin | officer: Chief Financial Officer | DROR 3/10, ZICHRON YAAKOV L3 3090216 |
Simon Sharon | officer: General Manager & CTO | 8 HAMADA STREET, ZICHRON YAACOV L3 3090708 |
Yoseph Bornstein | director, 10 percent owner | 16 IRUS STREET, ROSH HA'AYIN L3 4858022 |
Tal Baruch Wenderow | director | 1149, BEACON STREET, NEWTON MA 02461 |
Eyal Morag | officer: Chief Medical Officer | BONEY HAEAR 3 STREET, APT #13, TEL AVIV L3 6937303 |
Aileen Ptucha Stockburger | director | 26 WELLINGTON CT, BELLE MEADE NJ 08502 |
Harel Gadot | director, 10 percent owner, officer: Chairman and CEO | 5 VILLAGE LANE, HINGHAM MA 02043 |
Joseph Mona | 10 percent owner | 808 HAMPTON ST, COLUMBIA SC 29201 |
Prattipati Laxminarain | director | 3 HEWINS FARM ROAD, WELLESLEY MA 02481 |
Yoav Zvi Waizer | director | 8 HAVERED STREET, RAANANA L3 4352308 |
Moshe Shoham | director | 22 BEDOLACH STREET, HOSHAYA L3 1791500 |
Leon Lewkowicz | 10 percent owner | GORDON STREET 10, APARTMENT 7, TEL-AVIV L3 63458 |
Martin J. Madden | director | C/O MICROBOT MEDICAL INC., 175 DERBY STREET 27/1, HINGHAM MA 02043 |
Yehezkel Himelfarb | officer: General Manager & COO | 32 BEN YOSEF STREET, TEL-AVIV L3 6912530 |
Sandra Berkson | 10 percent owner | C/O SABER HOLDING GMBH, WEIN KRUMMBAUMGASSE C4 1020 |
From GuruFocus
By Marketwired • 07-18-2024
By Marketwired • 06-03-2024
By Marketwired • 10-24-2023
By Marketwired • 08-15-2023
By Marketwired • 10-19-2023
By Marketwired • 07-11-2023
By Marketwired • 06-20-2024
By Marketwired • 07-08-2024
By Marketwired • 06-04-2024
By Marketwired • 07-25-2023
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.